Oculocutaneous albinism type 4: Novel compound heterozygous mutations in the SLC45A2 gene in a Chinese case
Molecular Genetics & Genomic Medicine · 2024
DOI: 10.1002/mgg3.2385 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, 2024. Verfasst von Danyue He und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, P.R. China. Hauptthemen laut MEDLINE: Albinism, Oculocutaneous. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: the Fan Xing Teaching Reform Research Project of First Affiliated Hospital of Anhui Medical University, the 2020 Research Fund Project of Anhui Medical University, the Peking Union Medical College Hospital Public Welfare Project for Rare Disease Service Improvement.
Abstract (Originalsprache)
Background
Oculocutaneous albinism type 4 (OCA4) is a rare autosomal recessive disorder characterized by a reduction of pigmentation in skin, hair, and eyes, and OCA4 is mainly seen in the SLC45A2 gene variants.
Objective
To report a Chinese patient suspected of oculocutaneous albinism and identify the causing mutation. Method s Genomic DNA was extracted from the peripheral blood samples of the patient, his parents, and elder brother. Whole exome sequencing was performed in the family, and Sanger sequencing was then used to verify the mutations.
Results
Compound heterozygous variants, c.1304C>A (p.S435Y) and c.301C>G (p.R101G) in SLC45A2 gene, were detected in the proband, which were inherited from his father and mother respectively. Based on the ACMG guidelines, we can interpret the c.1304C>A (p.S435Y) variant as a suspected pathogenic variant and the c.301C>G (p.R101G) variant as a clinically significant unspecified variant. The diagnosis of OCA4 is confirmed.
Conclusion
We firstly reported this case of OCA4 with the compound heterozygous variants in the SLC45A2 gene. Our findings further enrich the reservoir of SLC45A2 mutations in OCA4.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, P.R. China.
- Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei, Anhui, P.R. China.
- Key Laboratory of Major Autoimmune Diseases, Hefei, Anhui, P.R. China.
ORCID-Profile: Xing Fan
Förderung
- the Fan Xing Teaching Reform Research Project of First Affiliated Hospital of Anhui Medical University
- the 2020 Research Fund Project of Anhui Medical University
- the Peking Union Medical College Hospital Public Welfare Project for Rare Disease Service Improvement
Zitieren
APA
He, D., Liu, X., Yao, T., Hu, J., Zheng, X., Tang, L., & Fan, X. (2024). Oculocutaneous albinism type 4: Novel compound heterozygous mutations in the SLC45A2 gene in a Chinese case. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.2385
Vancouver
He D, Liu X, Yao T, Hu J, Zheng X, Tang L, et al. Oculocutaneous albinism type 4: Novel compound heterozygous mutations in the SLC45A2 gene in a Chinese case. Molecular Genetics & Genomic Medicine. 2024. doi:10.1002/mgg3.2385
BibTeX
@article{He2024,
author = {He, Danyue and Liu, Xiaonan and Yao, Tianyu and Hu, Jie and Zheng, Xiaodong and Tang, Lili and Fan, Xing},
title = {Oculocutaneous albinism type 4: Novel compound heterozygous mutations in the SLC45A2 gene in a Chinese case},
journal = {Molecular Genetics & Genomic Medicine},
year = {2024},
doi = {10.1002/mgg3.2385}
}
EUVIMED